BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Interleukin-2 (IL-2)

May 7, 2015 7:00 AM UTC

Mouse studies suggest an IL-2 fusion protein could help treat cancer by boosting the efficacy of tumor-targeting mAbs. Mouse IL-2 was fused to the Fc domain of mouse immunoglobulin G2a (IgG2a) to exte...